VRXA Veraxa Biotech AG
Company Analysis
Latest News
🟢 Veraxa Biotech is trading 13.59% up in pre-market with no clear catalyst identified
Veraxa Biotech is trading at $1.17, up +13.59% in pre-market on October 23, 2026, with no clear company-specific catalyst identified in available coverage. -...
🟢 Veraxa Biotech is trading 11% up today as XBI rises 2.10%
Veraxa Biotech is trading at $1.12, up 10.89%, in a move that appears consistent with a broader biotech-sector rally. - XBI is up 2.10% in the provided market...
🟢 Veraxa Biotech is trading 8% up today amid a biotech-sector rally
Veraxa Biotech is trading at $1.09, up 7.92%, amid a biotech-sector rally; no company-specific catalyst was identified. - XBI was up during the session amid...
🟢 Veraxa Biotech is trading 5.9% up in pre-market with biotech ETF XBI up 3.64%
Veraxa Biotech is trading at $1.07, up 5.94%, with broader biotech strength offering sector-level support. - Biotech ETF XBI was up 3.64% pre-market,...
🟢 Veraxa Biotech is trading 5% up today
Veraxa Biotech is trading at $1.01, up 5.00%, with no confirmed company-specific catalyst for the October 20 move. - Its latest company releases were October...
🟢 Veraxa Biotech is trading 7% up in pre-market with no confirmed catalyst
Veraxa Biotech is trading at $1.07, up 7.00%, in pre-market, with no specific reason confirmed. - No clear company-specific catalyst dated October 20, 2026,...
🔴 Veraxa Biotech is trading 6.8% down with no clear catalyst identified
Veraxa Biotech is trading at $1.03, down 6.76%, with the reason for the decline unclear. - No company-specific announcement dated October 19 was found; the...
🟢 Veraxa Biotech is trading 6.36% up in after-hours trading
Veraxa Biotech is trading at $1.17, up 6.36%, with the move’s cause unconfirmed. - The company’s investor-relations page lists October 13 as its latest...
🟢 Veraxa Biotech is trading 9% up in pre-market with no confirmed catalyst
Veraxa Biotech is trading 9.01% up in pre-market at $1.21; no clear company-specific or market-driven reason for the gain is confirmed. - October 14 close:...
🔴 Veraxa Biotech is trading 8.1% down today with no confirmed company-specific catalyst
Veraxa Biotech is trading 8.1% lower at $1.10, with no verified company-specific announcement explaining the decline. - The October 13 BiTAC-ADC...
🔴 Veraxa Biotech is trading 5% down in pre-market as the cause remains unclear
Veraxa Biotech is trading 5.3% down now at $1.14, based on the provided pre-market price context; the cause is unclear. - No verified announcement on October...
🔴 Veraxa Biotech is trading 5.8% down in after-hours trading
Veraxa Biotech is trading 5.8% down at $1.13 in after-hours, with no clear company-specific or broad-market catalyst verified. - The regular-session close was...
Veraxa's Tumor-Shrinking Data Sends Shares Up 12% — But Can a $1.28 Micro-Cap Turn Mouse Results Into Real Medicine?
Shares of Veraxa Biotech surged 12.3% to $1.28 after the Zurich-based company unveiled its first animal-study results for a novel cancer-drug platform at the...
🟢 Veraxa Biotech is trading 11% up today after first in vivo BiTAC-ADC proof-of-concept data
Veraxa Biotech is trading at $1.28, up 10.53%, after presenting first in vivo proof-of-concept data for its BiTAC-ADC platform on October 13. - In a breast...
🟢 Veraxa Biotech is trading 5% up in pre-market following positive BiTAC-ADC breast cancer model results
Veraxa Biotech is trading at $1.20, up 5.28% in pre-market, reacting to the announcement of its BiTAC-ADC results. - On October 13, 2026, Veraxa Biotech...
🟢 Veraxa Biotech is trading 5% up in after-hours trading
Veraxa Biotech is trading at $1.20, up 5.26% after hours, with no clear company-specific catalyst identified. - The after-hours gain follows a 9.52% decline...
🔴 Veraxa Biotech is trading 10.22% down — decline catalyst remains unclear
Veraxa Biotech is trading 10.22% lower at $1.13; the reason for the decline remains unclear. - Its latest listed release, dated October 7, discussed...
🔴 Veraxa Biotech is trading 5.56% down with no clear catalyst identified
Veraxa Biotech is trading at $1.19, down 5.56%, during October 12, 2026 trading, with no clear catalyst identified. - Its October 7 release discussed...
🟢 Veraxa Biotech is trading 7.94% up in pre-market with no clear catalyst identified
Veraxa Biotech is trading at $1.36, up 7.94%, in pre-market, with no clear company-specific catalyst identified. - The latest company release, dated October...
🔴 Veraxa Biotech is trading 6.2% down in after-hours trading after reversing a 15.60% regular-session gain
Veraxa Biotech is trading 6.21% lower at $1.18 after reversing its 15.60% regular-session gain, with no clear after-hours catalyst identified. - It closed at...